Article
Vitamin D receptor ligands, adenomatous polyposis coli, and the vitamin D receptor FokI polymorphism collectively modulate beta-catenin activity in colon cancer cells.
Molecular carcinogenesis - 1 Apr 2010
Egan Jan B, Thompson Patricia A, Vitanov Milen V, Bartik Leonid, Jacobs Elizabeth T, Haussler Mark R, Gerner Eugene W, Jurutka Peter W
Abstract excerpt
The activity of beta-catenin, commonly dysregulated in human colon cancers, is inhibited by the vitamin D receptor (VDR), and this mechanism is postulated to explain the putative anti-cancer activity of vitamin D metabolites in the colon. We investigated the effect of a common FokI restriction si...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
